Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Today in Medicine.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKT
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Rocket Pharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ: RCKT). Such investors are advised to contact Danielle Peyton...

YOUUniverse Platform Supports Medicaid’s New Work Requirement Documentation Challenge
In 2026, millions of able-bodied adults enrolled in Medicaid are required to verify their participation in work, education, or approved community engagement. DALLAS, TX, UNITED STATES, July 10, 2025 /EINPresswire.com/ -- In response to the new...

Intelligent Bio Solutions to Present PK Study Data at Association for Diagnostics and Laboratory Medicine 2025 Clinical Lab Expo
Data shows excretion of codeine in fingerprint sweat INBS’ System is viable option for non-invasive diagnostic testing NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical...

Avricore Health’s HealthTab™ Platform Expands to North Central London in Groundbreaking NHS Pharmacy-Led Cardiovascular Project
VANCOUVER, British Columbia, July 10, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) is pleased to announce the expansion of its HealthTab™ platform into pharmacies in North Central London—making it the...

OSS Announces $2 Million Follow-On Production Order from Innovative Medical Imaging OEM
ESCONDIDO, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- One Stop Systems, Inc. (OSS or the Company) (Nasdaq: OSS), a leader in rugged Enterprise Class compute for artificial intelligence (AI), machine learning (ML) and sensor processing at the edge,...

Merck Reveals Acquiring UK’s Verona Pharma
(MENAFN) Merck, a German drugmaker, revealed on Wednesday that it has finalized a deal to purchase the UK-headquartered Verona Pharma for $10 billion, or $107 per share. This strategic acquisition is aimed at enhancing Merck’s range of treatments...

German Merck Seals USD10B Deal to Purchase UK’s Verona Pharma
(MENAFN) German pharmaceutical giant Merck revealed on Wednesday that it has finalized a $10 billion agreement to purchase UK-based Verona Pharma at $107 per share. This strategic move aims to broaden Merck’s portfolio of treatments targeting...

Tonix Pharmaceuticals Announces Presentation of New Data on Mpox and Smallpox Vaccine Candidate TNX-801 at the Vaccine Congress 2025
TNX-801 is up to 100,000-fold less virulent than live smallpox vaccine strains and a single dose provides robust immunogenicity and protection against mpox and rabbitpox (more than one year) in animals Subcutaneous administration of TNX-801...

Rhythm Pharmaceuticals, Inc. Announces Pricing of Upsized Public Offering of Common Stock
BOSTON, July 10, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) (“Rhythm”), a global, commercial-stage biopharmaceutical company dedicated to transforming the lives of patients living with rare neuroendocrine diseases, today...

Closed Suction Catheter Recall: Avanos Medical, Inc. Removes Ballard Closed Suction Systems Due to Risk of Non-Sterility
This recall involves updating instructions for using devices and does not involve removing them from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you...

Closed Suction Catheter Recall: Avanos Medical, Inc. Removes Ballard Closed Suction Systems Due to Risk of Non-Sterility
This recall involves updating instructions for using devices and does not involve removing them from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you...

Biogen and Stoke Therapeutics Announce Presentation of Data from Studies of Zorevunersen, an Investigational Medicine for Dravet syndrome, at the 16th European Paediatric Neurology Society (EPNS) Congress
– Data from an analysis designed to evaluate the potential effects of the Phase 3 zorevunersen dosing regimen showed improvements in cognition and behavior at Week 68 – – These findings support the inclusion of key secondary endpoints assessing...

Medical Teams International Makes Progress Against Sexual and Gender-Based Violence in Ethiopia
ADDIS ABABA, Ethiopia, July 09, 2025 (GLOBE NEWSWIRE) -- Medical Teams International, a global health and humanitarian relief organization, has expanded and enhanced our services in Ethiopia addressing gender-based violence (GBV) and life-saving...

Secarna Pharmaceuticals and Vect-Horus Announce Research Collaboration to Advance Systemic Delivery of RNA-Targeted Therapeutics for CNS Disorders
The partnership combines Secarna’s OligoCreator® technology with Vect-Horus’ VECTrans® platform to enable systemic delivery of oligonucleotide therapies across the blood-brain barrier This collaboration marks a strategic step for both companies in...

Medical Supplierz Expands as Global B2B Marketplace for Medical Equipment Trade
KUWAIT, KUWAIT, July 9, 2025 /EINPresswire.com/ -- Medical Supplierz, a digital B2B platform designed specifically for the medical sector, is gaining rapid traction as a trusted online space for global suppliers and healthcare buyers. With...

Department of Justice Subpoenas Doctors and Clinics Involved in Performing Transgender Medical Procedures on Children
WASHINGTON — Today, the Department of Justice announced that it has sent more than 20 subpoenas to doctors and clinics involved in performing transgender medical procedures on children. The Department’s investigations include healthcare fraud,...

Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
BOSTON, July 09, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) (“Rhythm”), a global, commercial-stage biopharmaceutical company dedicated to transforming the lives of patients living with rare neuroendocrine diseases, today...

Inventiva names Jason Campagna as President of R&D and Chief Medical Officer and Martine Zimmermann as Executive Vice President of Regulatory Affairs and Quality Assurance
Jason Campagna, MD, PhD, joins Inventiva as President of R&D and Chief Medical Officer, succeeding Pierre Broqua, PhD, and Michael Cooreman, MD Martine Zimmermann, PharmD, joins as Executive Vice President of Regulatory Affairs and Quality...

Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA’s Clinical Hold on Gene Therapy Trial – Hagens Berman
SAN FRANCISCO, July 09, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit styled Ho v. Rocket Pharmaceuticals, Inc., et al., No. 3:25-cv-10049 (D. N.J.) has been filed and seeks to represent investors who purchased or otherwise acquired...

Idaho Bureau of Emergency Medical Services joins Idaho Military Division
Posted on Jul 9, 2025 | updated: Jul 9, 2025 The Idaho Military Division is excited to welcome the state’s Bureau of Emergency Medical Services into the organization. This transition, effective July 1, 2025, marks a significant step toward...